Stay updated on Roll-over Study for Continued Pegaspargase in Pediatric ALL Clinical Trial
Sign up to get notified when there's something new on the Roll-over Study for Continued Pegaspargase in Pediatric ALL Clinical Trial page.

Latest updates to the Roll-over Study for Continued Pegaspargase in Pediatric ALL Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new revision entry: v3.4.2. The older funding-status notice from v3.4.1 was removed.SummaryDifference0.8%

- Check21 days agoChange DetectedAn administrative notice about government funding status was added. The page revision shows v3.4.1 replacing the previous v3.4.0.SummaryDifference0.8%

- Check28 days agoChange DetectedThe updates are limited to display/UI elements: showing the glossary, green highlights for additions and red highlights for deletions, and the revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check35 days agoChange DetectedThe history shows the addition of revision v3.3.4 and the deletion of revision v3.3.3.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 was added to the Record History. HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed from the page.SummaryDifference0.2%

- Check86 days agoChange DetectedA new revision entry (v3.3.2) was added to the record history and the previous entry (v3.3.1) removed, reflecting an update to the page's revision log rather than changes to the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Roll-over Study for Continued Pegaspargase in Pediatric ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roll-over Study for Continued Pegaspargase in Pediatric ALL Clinical Trial page.